Balamurugan V, Hosamani M, Jayappa K D, Venkatesan B, Chauhan R, Singh A. 2009. A polymerase chain reaction strategy for the diagnosis of camelpox. Vet Diag Invest, 21: 231–237.
Article
Google Scholar
Binns M, Mumford J, Wernery W. 1992. Analysis of the Camelpox virus thymidine kinase gene. Br Vet J, 148: 541–546.
PubMed
Article
CAS
Google Scholar
Dietzschold B, Wunner W H, Wiktor T J, Lopes A D, Lafon M, Smith C L, Koprowski H. 1983. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci. USA, 80:70–74.
PubMed
Article
CAS
Google Scholar
Duraffour S, Meyer H, Andrei G, Snoeck R. 2011. Camelpox virus. Antiviral Res, 92(2):167–86.
PubMed
Article
CAS
Google Scholar
Hafez S M, Al-Sukayran A, Dela Cruz D M, Mazloum K S, Al-Bokmy A M, Al-Mukayel A, Amjad A M. 1992. Development of a live cell culture camelpox vaccine. Vaccine, 10: 533–537.
PubMed
Article
CAS
Google Scholar
Khalafalla A I, Mohamed M E M. 1996. Clinical and epizootiological features of camelpox in eastern Sudan. J Camel Pract and Res, 2: 99–102.
Google Scholar
Khalafalla A I, Mohamed M E H, Ali B H. 1998. Camel pox in the Sudan. 1-isolation and identification of the causative virus. J Camel Pract and Res, 5: 229–233.
Google Scholar
Laidlaw S M, Skinner M A. 2004. Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European strain of fowlpox virus, with those of virulent American and European viruses. J Gen Virol, 85: 305–322.
PubMed
Article
CAS
Google Scholar
Massung R F, Esposito J J, Liu L Q, Utterback T R, Knight J C, Aubin L, Yuran T E, Parsons J M, Loparev V N, Selivanov N A, Cavallaro K F, Kerlavage A R, Mahy B W, Venter J C. 1993. Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature, 366: 748–751.
PubMed
Article
CAS
Google Scholar
Monath T P. 2005. Yellow fever vaccine. Expert Rev. Vaccines, 4: 553–574.
CAS
Google Scholar
Nguyen Ba-Vy, Guerre L, Martin-Sant G. 1996. Etude preliminaire de I innocuite e du pouvoir immunogene de la ouche attenuee VD47/25 de camelpox virus. Revue de Elev Med Vet Pays trop, 49: 189–194.
Google Scholar
Perkus M E, Goebel S J, Davis S W, Johnson G P, Limbach K, Norton E K, Paoletti E. 1991. Deletion of 55 open reading frames from the termini for vaccinia virus. Virology, 180: 406–410.
PubMed
Article
CAS
Google Scholar
Pfeffer M, Meyer H, Wernery U, Kaaden O R. 1996. Comparison of camelpox viruses isolated in Dubai. Vet Microbiol, 49: 135–146.
PubMed
Article
CAS
Google Scholar
Singh R K, Balamurugan V, Hosamani M, Kallesh D J, Bhanuprakash V. 2008. Sequence analysis of C18L gene of buffalopox virus: PCR strategy for specific detection and differentiation of buffalopox from orthopoxviruses. J Virol Methods, 154(1–2):146–153.
PubMed
Article
CAS
Google Scholar
Tulman E R, Afonso C L, Lu Z, Zsak L, Sur J H, Sandybaev N T, Karembekova U Z, Zaitsev V L, Kutish G F, Rock D L. 2002. The genomes of sheeppox and goatpox viruses. J Virol, 76: 6054–6061.
PubMed
Article
CAS
Google Scholar
Westrop G D, Wareham K A, Evans D M, Dunn G, Minor P D, Magrath D I, Taffs F, Marsden S, Skinner M A, Schild G C, Almond J W. 1989. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol, 63: 1338–1344.
PubMed
CAS
Google Scholar
Wernery U, Kaaden O R. 2002. Camel pox. In: Infectious Diseases in Camelids, Second Edition, Wernery U, Kaaden O R, eds, Blackwell Science Berlin, Vienna: 176–185.
Chapter
Google Scholar
Wernery U, Zachariah R. 1999. Experimental camelpox infection in vaccinated and unvaccinated dromedaries. J Vet Med (B) Infect Dis, 46: 131–136.
Article
CAS
Google Scholar